Adverts

Open Access Articles- Top Results for EGIS-12,233

EGIS-12,233

</th></tr>
EGIS-12,233
280px
Systematic (IUPAC) name
5,7-dichloro-3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-indolin-2-one
Clinical data
Identifiers
None
PubChem CID 11525867
Chemical data
Formula C24H28Cl3N3O
480.856 g/mol
 14pxY (what is this?)  (verify)

EGIS-12,233 is a drug with applications in scientific research, acting as a potent and selective antagonist for both the 5-HT6 and 5-HT7 serotonin receptor subtypes, with good selectivity over other receptors.[1] It has been shown to increase dopamine release in cochlear tissue, suggesting a role for the 5-HT6 and 5-HT7 receptors in regulation of the hearing system.[2]

References

  1. ^ Volk, B; Barkóczy, J; Hegedus, E; Udvari, S; Gacsályi, I; Mezei, T; Pallagi, K; Kompagne, H et al. (2008). "(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists". Journal of Medical Chemistry 51 (8): 2522–32. PMID 18361484. doi:10.1021/jm070279v. 
  2. ^ Doleviczényi, Z; Vizi, ES; Gacsályi, I; Pallagi, K; Volk, B; Hársing Jr, LG; Halmos, G; Lendvai, B; Zelles, T (2008). "5-HT6/7 receptor antagonists facilitate dopamine release in the cochlea via a GABAergic disinhibitory mechanism". Neurochemical research 33 (11): 2364–72. PMID 18663573. doi:10.1007/s11064-008-9796-4. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.